#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia A without inhibitors Congenital myopathy Leukaemia Adult T-cell lymphoma/leukaemia refractory Hidradenitis Deafness neurosensory HER2 mutant non-small cell lung cancer Hypophosphatasia Bulbospinal muscular atrophy congenital Frostbite Mucopolysaccharidosis II Chronic graft versus host disease in intestine Thrombotic microangiopathy Breast angiosarcoma Immune-mediated renal disorder More trials…

    Learn about Rare Diseases

    KBG syndrome – Diagnostics Ehlers-Danlos syndrome Mast cell activation syndrome – Life with Disease Primary immunodeficiency syndrome – Basic Information Primary mediastinal large B-cell lymphoma – Trials in Disease Haemophilia B with anti factor IX – Trials in Disease Andersen-Tawil syndrome – Trials in Disease Bronchiolitis obliterans syndrome – Basic Information Behcet’s syndrome – Diagnostics Alternating hemiplegia of childhood – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Perindopril Arginine Obexelimab Palbociclib MAGNESIUM CARBONATE HEAVY Delafloxacin Trametinib Dimethyl Sulfoxide M2Rlab Citicoline Sodium IMMUNOSTEM Riboflavin Sodium Phosphate TRIMIPRAMINE MALEATE Fulvestrant Glibenclamide Tisotumab Vedotin Db-Oto-5 Tebentafusp Dapagliflozin Autologous Chondrocytes Migalastat Calcium Folinate More therapies…

    Learn about Your Condition

    Systemic lupus erythematosus Hypersensitivity Tendon rupture Epithelioid sarcoma Gastrointestinal disorder Lyme disease Primary biliary cholangitis Bacterial vaginosis Cognitive disorder Tubulointerstitial nephritis Prinzmetal angina Fabry's disease Immunodeficiency Macular telangiectasia Bladder cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer
    Italy Spain

  • Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ripretinib
    • Sunitinib
    France Germany Hungary Italy The Netherlands Norway +2

  • Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Antiemetics And Antinauseants
    • Antipsychotics
    • Capecitabine
    Austria Belgium Czechia France Germany Greece +5

  • Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma stage IV
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    • Sunitinib
    Austria Belgium Czechia Denmark Finland France +7

  • Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Quavonlimab
    • Favezelimab
    • Mk-4830
    Belgium Denmark Estonia France Germany Greece +7

  • Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan
    France Italy

  • Study on Nemvaleukin Alfa and Pembrolizumab for Patients with Advanced Skin or Mucosal Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Nemvaleukin Alfa
    • Pembrolizumab
    Italy Spain

  • Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Renal cancer metastatic
    Investigated Drugs:
    • Cabozantinib
    • Ipilimumab
    • Nivolumab
    Belgium Czechia Finland France Germany Italy +3

  • Study of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Human Igg1K Monoclonal Antibody Against Tim-3
    • Tuparstobart
    • Retifanlimab
    France Greece Italy Portugal Spain

  • Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    France Germany Italy Norway Spain Sweden
Previous Page
1 … 39 40 41 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!